Vera Therapeutics finance chief accounting officer Young Joseph R exercised Options for 5,000 shares at $3.94 per share. The transaction left him with 80,754 shares and 33,589 derivative securities, while representing about 6.2% of his resulting shares and 13.0% of his prior derivative securities holding.
Key Highlights
- Young Joseph R’s option exercise occurred on 11 September 2026 under transaction code M.
- The transaction represented about 6.2% of his resulting share holding.
- His derivative securities holding stood at 33,589 after the exercise, with the transaction representing about 13.0% of his prior holding.
Vera Therapeutics, Inc. (NASDAQ: VERA) finance chief accounting officer Young Joseph R exercised options for 5,000 shares at $3.94 per share.
Option Exercise Changes Insider Holdings
The transaction took place on 11 September 2026. Young Joseph R held 80,754 shares after completing the transaction. The exercise price was $3.94 per share. Young Joseph R serves as senior vice president of finance and chief accounting officer at Vera Therapeutics.
Transaction Size Relative to Holdings
The 5,000-share exercise represented about 6.2% of Young Joseph R’s resulting share holding. The same transaction accounted for about 13.0% of his prior derivative securities holding.
FAQs
Q: What did Young Joseph R do at Vera Therapeutics?
A: Young Joseph R exercised options for 5,000 Vera Therapeutics shares at $3.94 per share. He serves as the company’s senior vice president of finance and chief accounting officer.
Q: How many Vera Therapeutics shares did Young Joseph R hold afterward?
A: Young Joseph R held 80,754 Vera Therapeutics shares after the option exercise. The transaction represented about 6.2% of his resulting share holding.
Q: What happened to Young Joseph R’s derivative securities?
A: Young Joseph R held 33,589 derivative securities following the transaction. The exercise represented about 13.0% of his prior derivative securities holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.